Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record history shows updated date entries (newly reflected 2026 dates) and removed prior 2025 date entries, indicating the page was refreshed with new record/update information.
    Difference
    0.3%
    Check dated 2026-04-23T14:58:36.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:08:55.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be a minor version update with no changes to the study data or main content.
    Difference
    0.1%
    Check dated 2026-03-18T18:26:00.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T15:25:21.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 was removed as part of page versioning; this is an administrative update that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:19:47.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government funding status notice at the top of the page and updated the version from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T01:17:39.000Z thumbnail image

Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.